Clinical trial

Treating the Partners of Drug Using Pregnant Women: Stage II

NCT00496990 · Johns Hopkins University, Other · Completed

Key facts

NCT number NCT00496990
Title Treating the Partners of Drug Using Pregnant Women: Stage II
Official title Treating the Partners of Drug Using Pregnant Women: Stage II
Acronym HOPE
Lead sponsor Johns Hopkins University, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Drug Addiction
Intervention type Behavioral
Interventions Enhanced care, control
Enrollment 158
Start date Oct 1, 2005
Primary completion Jun 1, 2009
Completion Jun 1, 2010
First posted Jul 6, 2007
Last update posted Mar 5, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies